Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,705
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Troy MI, Clinton Township MI, Auburn Hills MI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
IC-8 Apthera IOL New Enrollment Post Approval Study
Location: Birmingham MI, Indianapolis IN, Rock Island IL,
Sponsor: Bausch & Lomb Incorporated
Sex: All
Age: 22+
Code: NCT06060041
Recruiting
New
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Troy MI, Indianapolis IN, Plymouth Meeting PA,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase3, Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
for
Chronic Inducible Urticaria, Cold Urticaria,
Location: Troy MI, Skokie IL, Louisville KY, Baltimore MD,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT07266402
Phase3, Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
for
Vitiligo, Non-Segmental Vitiligo (NSV)
Location: Troy MI, London, Toronto, Richmond Hill,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07533019
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
for
Atopic Dermatitis
Location: Troy MI, Chicago IL
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07277660
Phase2, Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Troy MI, Waterford MI, Ann Arbor MI, London, Waterloo,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase3, Recruiting
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
for
NMIBC
Location: Troy MI, Cynwyd PA, Nashville TN, Atlanta GA,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06800963
Phase1, Phase2, Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Troy MI, Indianapolis IN, Chicago Ridge IL, Syracuse NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Troy MI, Gahanna OH, Merrillville IN, Cincinnati OH,
Sponsor: Dendreon
Sex: Male
Age: 18+
Code: NCT06134232
Phase2, Recruiting
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for
Non-muscle-invasive Bladder Cancer
Location: Troy MI, Columbus OH, Annapolis MD, Boston MA,
Sponsor: SURGE Therapeutics
Sex: All
Age: 18+
Code: NCT05710848
Phase1, Phase2, Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE),
Location: Troy MI, Flint MI, Indianapolis IN, Fairport NY,
Sponsor: Ventus Therapeutics U.S., Inc.
Sex: All
Age: 18 - 70+
Code: NCT07260877
Phase2, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Bingham Farms MI, Cleveland OH, South Bend IN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06740630
Phase3, Recruiting
New
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
for
Diabetes Mellitus, Type 2
Location: Southfield MI, Charlottesville VA, Iowa City IA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 10 - 18
Code: NCT07282613
Phase3, Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus